Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

HKG/1302 stock hub

HKG/1302 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HKG/1302is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
9.3B
Hong Kong Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
HKG/1302
In the news

Latest news · HKG/1302

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.4
P25 11.7P50 18.9P75 41.4
Trailing P/E54.5
P25 10.7P50 17.9P75 38.5
ROE3.2
P25 -14.7P50 2P75 9.4
ROIC4.9
P25 -10.4P50 1.9P75 10.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HKG/1302 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
230
Groups with data
11
Currency
CNY
Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Cayman Islands
Country code
HK
Employees
1,245
Employees Change
-150%
Employees Change Percent
-10.75
Enterprise value
HKD 8B
Exchange
Hong Kong Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Medical Devices
Isin
KYG548721177
Last refreshed
2026-05-10
Market cap
HKD 9.3B
Price
HKD 2
Price currency
HKD
Rev Per Employee
1,224,340.65x
Sector
Healthcare
Sic
3841
Symbol
hkg/1302
Website
https://www.lifetechmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
1.78%
EV Earnings
48.33x
EV/EBIT
35.44x
EV/EBITDA
23.53x
EV/FCF
14.86x
EV/Sales
5.22x
FCF yield
5.78%
Forward P/E
17.37x
P/B ratio
2.4x
P/E ratio
54.46x
P/S ratio
6.08x
PE Ratio10 Y
44.33x
PE Ratio3 Y
57x
PE Ratio5 Y
46.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
14.27%
EBITDA Margin
21.3%
FCF margin
35.1%
Gross margin
74.4%
Gross Profit
HKD 1.1B
Gross Profit Growth
5.74%
Gross Profit Growth Q
11.87%
Gross Profit Growth3 Y
0.43%
Gross Profit Growth5 Y
1.69%
Net Income
HKD 164.5M
Net Income Growth
-33.53%
Net Income Growth Q
451.08%
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Net Income Growth3 Y
-15.91%
Net Income Growth5 Y
-14.87%
Pretax Margin
13.98%
Profit Margin
10.79%
Profit Per Employee
HKD 132,131
Profitable Years
11
ROA
2.46
Roa5y
4.85
ROCE
5.53
ROE
3.23
Roe5y
6.98
ROIC
4.92
Roic5y
13.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

25
MetricValue
Cagr10y
3.86%
Cagr1y
26.6%
Cagr3y
-9.29%
Cagr5y
-12.55%
EPS Growth
-35.02
EPS Growth Q
412.7
EPS Growth Quarters
1
EPS Growth Years
0
EPS Growth3 Y
-16.04
EPS Growth5 Y
-15.14
FCF Growth
285.19%
FCF Growth Q
-45.26%
FCF Growth3 Y
216.61%
FCF Growth5 Y
24.73%
OCF Growth
70.87%
OCF Growth Q
-27.78%
OCF Growth10 Y
4.96%
OCF Growth3 Y
22.67%
OCF Growth5 Y
8.38%
Revenue Growth
5.07x
Revenue Growth Q
6.48x
Revenue Growth Quarters
11x
Revenue Growth Years
5x
Revenue Growth3 Y
2.27x
Revenue Growth5 Y
3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
HKD 0.28
Assets
HKD 5.6B
Cash
HKD 1.3B
Current Assets
HKD 2.7B
Current Liabilities
HKD 1.7B
Debt
HKD 8.9M
Debt EBITDA
HKD 0.03
Debt Equity
HKD 0
Debt FCF
HKD 0.02
Equity
HKD 3.9B
Interest Coverage
930.5
Liabilities
HKD 1.7B
Long Term Assets
HKD 2.9B
Long Term Liabilities
HKD 7.1M
Net Cash
HKD 1.3B
Net Cash By Market Cap
HKD 13.72
Net Cash Growth
-2.96%
Net Debt EBITDA
HKD -3.91
Net Debt Equity
HKD -0.33
Net Debt FCF
HKD -2.38
Tangible Book Value
HKD 3.7B
Tangible Book Value Per Share
HKD 0.8
WACC
6.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.57
Inventory Turnover
0.72
Net Working Capital
HKD -334.5M
Quick ratio
1.19
Working Capital
HKD 941.1M
Working Capital Turnover
HKD 1.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
45.99%
1Y total return
26.58%
200-day SMA
1.86
3Y total return
-25.37%
50-day SMA
1.82
50-day SMA vs 200-day SMA
50under200
5Y total return
-48.85%
All Time High
5.98
All Time High Change
-66.56%
All Time High Date
2021-01-25
All Time Low
0.19
All Time Low Change
952.63%
All Time Low Date
2011-11-10
ATR
0.09
Beta
0.39
Beta1y
0.31
Beta2y
0.09
Ch YTD
28.21
High
2.05
High52
2.44
High52 Date
2025-10-08
High52ch
-18.03%
Low
1.98
Low52
1.47
Low52 Date
2025-12-18
Low52ch
36.05%
Ma50ch
10.07%
Price vs 200-day SMA
7.64%
RSI
54.51
RSI Monthly
52.29
RSI Weekly
59.54
Sharpe ratio
0.86x
Sortino ratio
1.44
Total Return
-0.54%
Tr YTD
28.21
Tr1m
9.89%
Tr1w
-4.31%
Tr3m
17.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
HKD 217.4M
Operating Income Growth
184.1
Operating Income Growth Q
333.1
Operating Income Growth3 Y
-9.37
Operating Income Growth5 Y
-12.95
Operating margin
14.27

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
3,589,587,472%
Net Borrowing
-5,202,761.9
Shares Insiders
12.96%
Shares Institutions
11.73%
Shares Out
4,631,712,400
Shares Qo Q
3.1%
Shares Yo Y
0.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
HKD 286.6M
Average Volume
29,172,422.4x
Bv Per Share
0.84
CAPEX
HKD -76.2M
Ch10y
45.99
Ch1m
9.89
Ch1w
-4.31
Ch1y
26.58
Ch3m
17.65
Ch3y
-25.37
Ch5y
-48.85
Ch6m
5.26
Change
-1.48%
Change From Open
-2.44
Close
2.03
Days Gap
0.99
Depreciation Amortization
110,930,068.7
Dollar Volume
22,856,896
Earnings Date
2026-08-28
EBIT
HKD 217.4M
EBITDA
HKD 324.6M
EPS
HKD 0.04
F Score
6
FCF
HKD 535M
FCF EV Yield
6.73x
FCF Per Share
HKD 0.12
Financing CF
-411,493,861
Fiscal Year End
December
Founded
1,999
Graham Number
0.83506
Graham Upside
-58.25
Income Tax
HKD 88M
Investing CF
-141,747,544
Is Primary Listing
1
Last Earnings Date
2026-03-31
Last Report Date
2025-12-31
Last Split Date
2015-01-12
Last Split Type
Forward
Lynch Fair Value
HKD 0.18
Lynch Upside
-90.82
Ma150
1.82
Ma150ch
10.13%
Ma20
1.98
Ma20ch
0.86%
Net CF
59,602,117
Next Earnings Date
2026-08-28
Open
2.05
P FCF Ratio
17.31
P OCF Ratio
15.16
Position In Range
28.57
Ppne
1,115,295,724.7
Price Date
2026-05-08
Price EBITDA
HKD 28.53
Ptbv Ratio
2.51
Relative Volume
0.38x
Revenue
1,524,304,109x
SBC By Revenue
16.3x
Share Based Comp
248,478,287
Tax By Revenue
5.77x
Tax Rate
41.3%
Tr6m
5.26%
Volume
11,428,448
Z Score
4.07
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HKG/1302 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/1302 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+26.6%
S&P 500 1Y: n/a
3Y total return
-25.4%
S&P 500 3Y: n/a
5Y total return
-48.8%
S&P 500 5Y: n/a
10Y total return
+46.0%
S&P 500 10Y: n/a
Ownership

Who owns HKG/1302?

Insider, institutional, and short-interest positioning.

Institutional ownership
+11.7%
Share of float held by funds and institutions
Insider ownership
+13.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.5%
Negative means the company is buying back shares.
Technical

HKG/1302 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
54.5
Neutral momentum band
Price vs 200-day MA
+7.6%
50/200-day relationship not available
Beta (5Y)
0.39
Less volatile than the market
Sharpe ratio
0.86
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HKG/1302

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1302 stock rating?

hkg/1302 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1302 analysis?

The full report lives at /stocks/hkg/1302/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1302?

The latest report frames hkg/1302 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1302 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.